ENTITY
Shanghai MicroPort Endovascula

Shanghai MicroPort Endovascula (688016 CH)

37
Analysis
Health CareChina
Shanghai MicroPort Endovascular MedTech (Gruop) Co., Ltd. develops and sells medical instruments. The Company manufactures and sells peripheral vascular stents, aortic balloon dilation catheters, aortic stent grafts, and other related products. Shanghai MicroPort Endovascular MedTech (Gruop) markets its products primarily throughout China with limited overseas.
more
27 Apr 2021 07:29

Pre-IPO Zylox-Tonbridge Medical Technology - Promising Market with Challenges

This insights analyzed Zylox-Tonbridge Medical Technology in terms of the market potential, industry characteristics, business analysis, financial...

Logo
448 Views
Share
bearishWuxi Biologics
05 Jan 2025 09:32

China Healthcare Weekly (Jan.5)-TCM VBP Update, Medical Device VBP Result Is Out, WuXi Bio's Outlook

VBP result of TCM Patent Medicine is released. VBP of cochlear implant/peripheral vascular stent is good for companies. Only when Li Ge buys big...

Logo
570 Views
Share
10 Mar 2024 19:55

China Healthcare Week (Mar.8) - GLP-1s, “Crowding Out Effect” in Healthcare, Microport's Trouble

The drug combination based on GLP-1s has become the largest target in history. “Crowding out effect” on non-rigid consumption is the key reason for...

Logo
514 Views
Share
27 May 2023 12:21

STAR50 Index Rebalance: Two Changes in June (As Expected)

There are 2 changes for the STAR50 Index as a 6-month minimum listing history is used. There is little increase in excess volume on the adds while...

Logo
656 Views
Share
15 May 2023 08:55

Acotec Scientific (6669.HK) - What Value Boston Scientific Will Bring Is Crucial to Future Valuation

There're many highlights in Acotec’s performance last year,but growth ceiling is obvious if rely solely on China market.Boston Scientific's...

Logo
441 Views
Share
x